Featured Archives - Page 47 of 49 - Pharma Marketing Network

How California and Texas Are Rewriting Pharma’s AI Compliance Playbook

Donna Pacheco - January 9, 2026

Training Marketers for Everyday AI: Building Literacy and Risk Awareness Inside...

Donna Pacheco - January 9, 2026

From ESG Reports to Real Messages: Making Sustainable Pharma Marketing Credible

Donna Pacheco - January 9, 2026

A symbolic image showing the European Union flag, pharmaceuticals, and regulatory symbols representing the EU pharma reform’s impact on drug marketing and access.

EU Pharma Reform and the Marketing Fallout: Adapting to a New...

Donna Pacheco - December 25, 2025

Pharmaceutical executive, doctor, and government official discussing drug pricing over money and medical tools, symbolizing pharma pricing communication

How Pharma Marketers Should Communicate Drug Price Negotiations

Donna Pacheco - January 1, 2026

Pharma marketing command center with professionals analyzing real-time data on digital screens.

Campaign Command Centers: A New Model for Real-Time Pharma Marketing Orchestration

Donna Pacheco - December 19, 2025

A hand holding a smartphone displaying "Fake News" surrounded by pills, social media icons, and a digital shield symbolizing pharma's battle against misinformation.

When Pharma Becomes a Punchline: Crisis Readiness in the Misinformation Age

Donna Pacheco - December 19, 2025

26th DTC National Conference

Pharma Guy - March 12, 2026

A digital scene showing a spilled pill bottle, stethoscope, and multiple screens displaying FDA and EMA safety alerts, representing real-time pharmaceutical safety communication.

Real-Time Risk: What Safety Bulletins Mean for Omnichannel Brand Perception

Donna Pacheco - December 25, 2025

Illustration of multiple pharma communication channels merging into a seamless digital health experience with a doctor and patient viewing health data.

Why Unified Experience Design Beats Omnichannel in Pharma Marketing

Donna Pacheco - December 7, 2025

1...464748 Page 47 of 48

Featured

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Cross-Functional Collaboration Drives Launch Success

Tactical Overload…Building a Linear & Cohesive Brand Plan

5 Trends That Will Shape Pharma Marketing in 2021

Why Is FDA Issuing Fewer Marketing Violation Letters?

How California and Texas Are Rewriting Pharma’s AI Compliance Playbook

Training Marketers for Everyday AI: Building Literacy and Risk Awareness Inside...

From ESG Reports to Real Messages: Making Sustainable Pharma Marketing Credible

EU Pharma Reform and the Marketing Fallout: Adapting to a New...

How Pharma Marketers Should Communicate Drug Price Negotiations

Campaign Command Centers: A New Model for Real-Time Pharma Marketing Orchestration

When Pharma Becomes a Punchline: Crisis Readiness in the Misinformation Age

26th DTC National Conference

Real-Time Risk: What Safety Bulletins Mean for Omnichannel Brand Perception

Why Unified Experience Design Beats Omnichannel in Pharma Marketing

EDITOR PICKS

26th DTC National Conference

Informa Connect 2026 Events

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

Pharma Marketing News – Past Issues (2016)

RECENT POSTS

The Algorithmic Gatekeeper: How Pharma Marketers Can Stay Visible in AI-Filtered...

When AI Speaks for Your Brand: What Pharma Marketers Must Do...

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

POPULAR CATEGORY